Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the aetiological agent of
coronavirus disease 2019 (COVID-19), an emerging respiratory infection caused by the …

There is concern that variola virus, the aetiological agent of smallpox, may be used as a
biological weapon. For this reason several countries are now stockpiling (vaccinia virus-based) …

The use of classical smallpox vaccines based on vaccinia virus (VV) is associated with
severe complications in both naïve and immune individuals. Modified vaccinia virus Ankara (…

Transmission of severe acute respiratory coronavirus-2 (SARS-CoV-2) between livestock
and humans is a potential public health concern. We demonstrate the susceptibility of rabbits …

Modified vaccinia virus Ankara (MVA)-based recombinant viruses have been shown to be
potent vaccine candidates for several infectious and neoplastic diseases. Since a major …

Immunocompromised individuals tend to suffer from influenza longer with more serious
complications than otherwise healthy patients. Little is known about the impact of prolonged …

Previously we have shown that a single dose of recombinant adenovirus serotype 26 (Ad26)
vaccine expressing a prefusion stabilized SARS-CoV-2 spike antigen (Ad26.COV2.S) is …

Background: Since the outbreak of coronavirus disease 2019 (COVID-19), many put their
hopes in the rapid availability of effective immunizations. Human milk, containing antibodies …

Background. The newly emerged influenza A(H1N1) virus (new H1N1 virus) is causing the
first influenza pandemic of this century. Three influenza pandemics of the previous century …

Humans may be infected by different influenza A viruses—seasonal, pandemic, and
zoonotic—which differ in presentation from mild upper respiratory tract disease to severe and …